Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Matthew on +44 1494 818 054 or matthew@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Matthew Moxon
Account Manager
matthew@zenopa.com
+44 1494 818 054

Testimonials
I just wanted to express my thanks for all the help and guidance Zenopa have provided me with over the past month. Zenopa have been very helpful throughout the interview and negotiation stages.
Allira, 2012

Baxter highlights success of Advate trials

4 August 2011 00:00 in Medical Company Product News


Baxter has revealed that additional trials of its Advate treatment have produced positive results, with the therapy demonstrating its safety, efficacy and inhibition capability.

Deborah Brady, business unit director for BioScience at the company, pointed out that this has previously been shown in clinical trial data, but it has now been backed up by the everyday experiences of international physicians.

Advate - or Antihaemophilic Factor (Recombinant), Plasma/Albumin-Free Method - was used on a broad range of patients, including those with severe to moderately severe haemophilia A and those who had been treated before.

"This publication provides further confidence to clinicians and patients that Advate
offers an effective, well-tolerated treatment," added Ms Brady.

Printed in the journal Haemophilia, the study focused on the experiences of pharmaceutical professionals in the US and 11 European Union nations.

Earlier this year, Baxter announced that it had raised more than £6,900 for Children in Need with the help of a Britain's Got Talent-style competition involving staff members. ADNFCR-8000103-ID-800690161-ADNFCR

Other news stories from 04/08/2011

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency



                    
© Copyright 2014 Zenopa Ltd